speb/financial-data huggingface dataset:
Financial ratios for PII — quarterly report dated 2025-12-31
Total revenue: 1921900000
Gross profit: 384200000
Operating income: -32000000
Net income: -303300000
Capital expenditures: 64700000
Operating cash flow: 178700000
Depreciation & amortization: 67600000
Net tangible assets: 28400000
Owner earnings: -300400000
Return on net tangible assets (%): -1057.7464788732393
Buffett classification: The Gruesome
Stock price: 61.94
Shares outstanding: 56886167
Book value: 832900000
P/B ratio: 4.230434846896386
Market cap (USD): 3523529183.98
Debt to equity: 1.9986793132428864
Current ratio: 0.9836401729594794
Quick ratio: 0.3540320064191147
Interest coverage ratio: -1.032258064516129
COGS to revenue (%): 80.00936573182787
R&D to revenue (%): 5.510172225401946
SG&A to revenue (%): 17.17050835111088
Free cash flow (dilution-adjusted): 103200000
Buyback yield (%): 0
Retained earnings: -469000000
Inventory turnover: 1.0887142452563012
Receivables turnover: 8.02463465553236
Capitalized R&D asset: 197875000
ROCI (R&D-adjusted, %): -0.7876112149751455
Rosenberg metric: 0.04202586206896552
FCF margin (%): 5.369686247983766
Revenue growth (%): 4.360338835794961
Rule of 40 score: 9.730025083778727
Financial ratios for PII — annual report dated 2025-12-31
Total revenue: 7152000000
Gross profit: 1368700000
Operating income: 34300000
Net income: -464800000
Capital expenditures: 182900000
Operating cash flow: 741000000
Depreciation & amortization: 286500000
Net tangible assets: 28400000
Owner earnings: -361200000
Return on net tangible assets (%): -1271.830985915493
Capex to operating income (%): 533.2361516034985
Buffett classification: The Gruesome
Stock price: 61.94
Shares outstanding: 56886167
Book value: 832900000
P/B ratio: 4.230434846896386
Market cap (USD): 3523529183.98
Debt to equity: 1.9986793132428864
Current ratio: 0.9836401729594794
Quick ratio: 0.3540320064191147
Interest coverage ratio: 0.2610350076103501
COGS to revenue (%): 80.86269574944072
R&D to revenue (%): 5.199944071588367
SG&A to revenue (%): 14.636465324384787
Free cash flow (dilution-adjusted): 498200000
Buyback yield (%): 0.06811352694088038
Retained earnings: -469000000
Inventory turnover: 4.0946615689606345
Receivables turnover: 29.862212943632567
Capitalized R&D asset: 721142000
ROCI (R&D-adjusted, %): 1.339644194456622
Rosenberg metric: -0.29118432769367764
FCF margin (%): 6.965883668903803
Revenue growth (%): -0.32611422359729075
Rule of 40 score: 6.639769445306513
Financial ratios for PMV.AX — annual report dated 2021-07-31
Total revenue: 1069017777.7777777
Gross profit: 687335555.5555555
Operating income: 237588148.14814812
Net income: 201362962.96296296
Capital expenditures: 2160740.7407407407
Depreciation & amortization: 132042962.96296296
Net tangible assets: 522889629.6296296
Owner earnings: 331245185.1851852
Return on net tangible assets (%): 63.348968198090105
Capex to operating income (%): 0.9094480333225251
Buffett classification: The Great
Stock price: 16.296296296296294
P/E ratio: 12.910113500588581
Shares outstanding: 159522057
Book value: 1135485185.1851852
P/B ratio: 2.2894342793584728
Market cap (USD): 2599618706.6666665
Debt to equity: 0.2507128621799785
Current ratio: 1.482194257950875
Quick ratio: 1.074525173702649
Effective tax rate (%): 28.384569382717352
Interest coverage ratio: 65.4846876276031
COGS to revenue (%): 35.704010742987336
SG&A to revenue (%): 26.11015719518229
Free cash flow (dilution-adjusted): 281842222.2222222
Buyback yield (%): 0
Retained earnings: 692067407.4074074
Inventory turnover: 2.4682458325349685
Receivables turnover: 152.07312961011593
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.129938840340504
FCF margin (%): 26.364596368837024
Rule of 40 score: 26.364596368837024
Financial ratios for PMV.AX — annual report dated 2022-07-31
Total revenue: 1047216783.2167833
Gross profit: 678181118.8811189
Operating income: 238518181.81818184
Net income: 199422377.62237763
Capital expenditures: 6049650.3496503495
Depreciation & amortization: 116206993.00699301
Net tangible assets: 594609790.2097902
Owner earnings: 309579720.2797203
Return on net tangible assets (%): 52.06434965870548
Capex to operating income (%): 2.5363476710810624
Buffett classification: The Great
Stock price: 12.531468531468533
P/E ratio: 10.024179137789561
Shares outstanding: 159522057
Book value: 1173090209.7902098
P/B ratio: 1.7040851766447953
Market cap (USD): 1999045637.3706298
Debt to equity: 0.18377198708330578
Current ratio: 1.8183678540998904
Quick ratio: 1.2493533695784478
Effective tax rate (%): 27.37436427674622
Interest coverage ratio: 104.72244396684066
COGS to revenue (%): 35.239662909343444
SG&A to revenue (%): 27.254327154228324
Free cash flow (dilution-adjusted): 242379720.27972028
Buyback yield (%): 0
Retained earnings: 750483216.7832168
Inventory turnover: 2.3517817034475383
Receivables turnover: 135.8171594413205
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.854073164424708
FCF margin (%): 23.14513328703456
Revenue growth (%): -2.0393481768201496
Rule of 40 score: 21.105785110214413
Financial ratios for PMV.AX — annual report dated 2023-07-31
Total revenue: 1095668000
Gross profit: 681660666.6666666
Operating income: 233535333.33333334
Net income: 180718666.66666666
Capital expenditures: 10876666.666666666
Depreciation & amortization: 106814666.66666667
Net tangible assets: 612648666.6666666
Owner earnings: 276656666.6666666
Return on net tangible assets (%): 45.15747470273882
Capex to operating income (%): 4.657396596660605
Buffett classification: The Great
Stock price: 13.373333333333333
P/E ratio: 11.804766389821381
Shares outstanding: 159522057
Book value: 1114890666.6666667
P/B ratio: 1.913498521481329
Market cap (USD): 2133341642.28
Debt to equity: 0.33984318940691344
Current ratio: 2.0456047095798757
Quick ratio: 1.3576292574911608
Effective tax rate (%): 29.06261366996653
Interest coverage ratio: 60.31387741046832
COGS to revenue (%): 37.785837802448675
SG&A to revenue (%): 27.553845386254476
Free cash flow (dilution-adjusted): 228402666.66666666
Buyback yield (%): 0
Retained earnings: 738016666.6666666
Inventory turnover: 2.686533395051848
Receivables turnover: 129.63416942735446
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.053237818226478
FCF margin (%): 20.845974023761453
Revenue growth (%): 4.626665420161326
Rule of 40 score: 25.47263944392278
Financial ratios for PRAX — annual report dated 2021-12-31
Capital expenditures: 1050000
Buffett classification: The Gruesome
Stock price: 295.5
Shares outstanding: 27878774
Market cap (USD): 8238177717
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRAX — annual report dated 2022-12-31
Total revenue: 0
Operating income: -214986000
Net income: -214029000
Capital expenditures: 444000
Operating cash flow: -185043000
Depreciation & amortization: 419000
Net tangible assets: 76106000
Owner earnings: -214054000
Return on net tangible assets (%): -281.25771949649175
Buffett classification: The Gruesome
Stock price: 35.7
Shares outstanding: 27878774
Book value: 76106000
P/B ratio: 13.077447662470764
Market cap (USD): 995272231.8000001
Debt to equity: 0.045988489737997004
Current ratio: 3.22725287523657
Quick ratio: 3.22725287523657
Free cash flow (dilution-adjusted): -214080000
Buyback yield (%): 0
Retained earnings: -530644000
Capitalized R&D asset: 155040000
ROCI (R&D-adjusted, %): -47.334653532522275
Rule of 40 score: 0
Financial ratios for PRAX — annual report dated 2023-12-31
Total revenue: 2447000
Operating income: -126373000
Net income: -123277000
Capital expenditures: 50000
Operating cash flow: -111136000
Depreciation & amortization: 432000
Net tangible assets: 69669000
Owner earnings: -122895000
Return on net tangible assets (%): -176.39839813977522
Buffett classification: The Gruesome
Stock price: 22.28
Shares outstanding: 27878774
Book value: 69669000
P/B ratio: 8.915573421751425
Market cap (USD): 621139084.72
Debt to equity: 0.035812197677589745
Current ratio: 5.38954854276462
Quick ratio: 5.38954854276462
COGS to revenue (%): 0
R&D to revenue (%): 3545.8111973845525
SG&A to revenue (%): 1718.594196975889
Free cash flow (dilution-adjusted): -136043000
Buyback yield (%): 0
Retained earnings: -653921000
Capitalized R&D asset: 190642800
ROCI (R&D-adjusted, %): -45.73435427698334
FCF margin (%): -5559.583163056805
Rule of 40 score: -5559.583163056805
Financial ratios for PRAX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 57.54
Shares outstanding: 27878774
Market cap (USD): 1604144655.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRAX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 76.96
Shares outstanding: 27878774
Market cap (USD): 2145550447.0399997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRAX — annual report dated 2024-12-31
Total revenue: 1000000
Operating income: -200165000
Net income: -182819000
Capital expenditures: 0
Operating cash flow: -131757000
Depreciation & amortization: 358000
Net tangible assets: 445450000
Owner earnings: -182461000
Return on net tangible assets (%): -40.96105062296554
Buffett classification: The Gruesome
Stock price: 76.96
Shares outstanding: 27878774
Book value: 445450000
P/B ratio: 4.81659096877315
Market cap (USD): 2145550447.0399997
Debt to equity: 0.003073296666292513
Current ratio: 10.7688948069241
Quick ratio: 10.7688948069241
COGS to revenue (%): 0
R&D to revenue (%): 15241.300000000001
SG&A to revenue (%): 5630.5
Free cash flow (dilution-adjusted): -173117000
Buyback yield (%): 0
Retained earnings: -836740000
Capitalized R&D asset: 261709420
ROCI (R&D-adjusted, %): -25.330988201544656
FCF margin (%): -17311.7
Revenue growth (%): -59.133633020024526
Rule of 40 score: -17370.833633020025
Financial ratios for PRAX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -74728000
Net income: -69296000
Capital expenditures: 0
Operating cash flow: -53010000
Depreciation & amortization: 47000
Net tangible assets: 439214000
Owner earnings: -69249000
Return on net tangible assets (%): -15.766573925239177
Buffett classification: The Gruesome
Stock price: 37.87
Shares outstanding: 27878774
Book value: 439214000
P/B ratio: 2.403769395738751
Market cap (USD): 1055769171.3799999
Debt to equity: 0.002427062889616451
Current ratio: 8.440235818025403
Quick ratio: 8.440235818025403
Free cash flow (dilution-adjusted): -61796000
Buyback yield (%): 0
Retained earnings: -906036000
Capitalized R&D asset: 60806000
ROCI (R&D-adjusted, %): -6.837859818940577
Rule of 40 score: 0
Financial ratios for PRAX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -76067000
Net income: -71127000
Capital expenditures: 56000
Operating cash flow: -54676000
Depreciation & amortization: 46000
Net tangible assets: 404224000
Owner earnings: -71137000
Return on net tangible assets (%): -17.598410782140594
Buffett classification: The Gruesome
Stock price: 42.05
Shares outstanding: 27878774
Book value: 404224000
P/B ratio: 2.9001307361759814
Market cap (USD): 1172302446.6999998
Debt to equity: 0.0018677762824572514
Current ratio: 6.307171658986175
Quick ratio: 6.307171658986175
Free cash flow (dilution-adjusted): -62502000
Buyback yield (%): 0
Retained earnings: -977163000
Capitalized R&D asset: 103746020
ROCI (R&D-adjusted, %): -10.695841196822336
Rule of 40 score: 0
Financial ratios for PRAX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -78359000
Net income: -73934000
Capital expenditures: 0
Operating cash flow: -65057000
Depreciation & amortization: 19000
Net tangible assets: 343505000
Owner earnings: -73915000
Return on net tangible assets (%): -21.51788183578114
Buffett classification: The Gruesome
Stock price: 53
Shares outstanding: 27878774
Book value: 343505000
P/B ratio: 4.301465836014032
Market cap (USD): 1477575022
Debt to equity: 0.0012692682784821183
Current ratio: 5.178299264413895
Quick ratio: 5.178299264413895
Free cash flow (dilution-adjusted): -72504000
Buyback yield (%): 0
Retained earnings: -1051097000
Capitalized R&D asset: 128077000
ROCI (R&D-adjusted, %): -16.066134839752152
Rule of 40 score: 0
Financial ratios for PRAX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -97044000
Net income: -88911000
Capital expenditures: 0
Operating cash flow: -76325000
Depreciation & amortization: 28000
Net tangible assets: 878136000
Owner earnings: -88883000
Return on net tangible assets (%): -10.121780680896808
Buffett classification: The Gruesome
Stock price: 294.74
Shares outstanding: 27878774
Book value: 878136000
P/B ratio: 9.357308946176904
Market cap (USD): 8216989848.76
Debt to equity: 0.0001252653347545255
Current ratio: 10.220859614194174
Quick ratio: 10.220859614194174
Free cash flow (dilution-adjusted): -86263000
Buyback yield (%): 0
Retained earnings: -1140008000
Capitalized R&D asset: 142381970
ROCI (R&D-adjusted, %): -8.65322015512051
Rule of 40 score: 0
Financial ratios for PRAX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -326198000
Net income: -303268000
Capital expenditures: 56000
Operating cash flow: -249068000
Depreciation & amortization: 140000
Net tangible assets: 878136000
Owner earnings: -303184000
Return on net tangible assets (%): -34.52585932019642
Buffett classification: The Gruesome
Stock price: 294.74
Shares outstanding: 27878774
Book value: 878136000
P/B ratio: 9.357308946176904
Market cap (USD): 8216989848.76
Debt to equity: 0.0001252653347545255
Current ratio: 10.220859614194174
Quick ratio: 10.220859614194174
Free cash flow (dilution-adjusted): -283065000
Buyback yield (%): 0
Retained earnings: -1140008000
Capitalized R&D asset: 397864490
ROCI (R&D-adjusted, %): -17.856393351907464
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for RAYMONDLSL.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 512967032.96703297
Buffett classification: The Gruesome
Stock price: 28.236024844720497
Shares outstanding: 60905789
Book value: 1141703296.7032967
P/B ratio: 1.5062909745089628
Market cap (USD): 1719737371.3913043
Debt to equity: 0.22121205146500333
Current ratio: 1.3802131085402163
Quick ratio: 0.8074345010350893
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RAYMONDLSL.NS — quarterly report dated 2024-12-31
Total revenue: 204477211.79624665
Gross profit: 86869098.96258305
Operating income: 11685511.131833546
Net income: 7479892.761394101
Capital expenditures: 0
Depreciation & amortization: 9259820.491898822
Owner earnings: 16739713.253292922
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 24.496444807087073
P/E ratio: 49.866199498578
Shares outstanding: 60905789
Market cap (USD): 1491975298.6705909
Effective tax rate (%): 26.028818443804035
Interest coverage ratio: 1.8424921889358574
COGS to revenue (%): 57.51648890383705
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RAYMONDLSL.NS — quarterly report dated 2025-03-31
Total revenue: 174672667.7577741
Gross profit: 72986906.71031097
Operating income: -9063595.978489595
Net income: -5254851.531447276
Capital expenditures: 0
Depreciation & amortization: 10647650.222118307
Net tangible assets: 505212765.95744675
Owner earnings: 5392798.690671031
Buffett classification: The Gruesome
Stock price: 12.198973042362002
Shares outstanding: 60905789
Book value: 1120838204.3488426
P/B ratio: 0.6628861108159955
Market cap (USD): 742988078.1347882
Debt to equity: 0.23891255938629383
Current ratio: 1.5020005280581676
Quick ratio: 0.9073427165207737
Interest coverage ratio: -1.4518726591760298
COGS to revenue (%): 58.21503865073788
Buyback yield (%): 0
Retained earnings: 302894552.2562544
Inventory turnover: 0.49513021203927704
Receivables turnover: 1.6291050634567579
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7124753487021425
Revenue growth (%): -14.57597341857907
Rule of 40 score: -14.57597341857907
Financial ratios for RAYMONDLSL.NS — annual report dated 2025-03-31
Total revenue: 716209960.2525134
Gross profit: 305404489.1278934
Operating income: 30579845.686228663
Net income: 4464577.975216273
Capital expenditures: 25251344.40028057
Operating cash flow: 47264437.6899696
Depreciation & amortization: 37567220.01402852
Net tangible assets: 505212765.95744675
Owner earnings: 16780453.58896422
Return on net tangible assets (%): 3.3214627023850007
Capex to operating income (%): 82.57512042205062
Buffett classification: The Gruesome
Stock price: 12.198973042362002
P/E ratio: 166.41843467831836
Shares outstanding: 60905789
Book value: 1120838204.3488426
P/B ratio: 0.6628861108159955
Market cap (USD): 742988078.1347882
Debt to equity: 0.23891255938629383
Current ratio: 1.5020005280581676
Quick ratio: 0.9073427165207737
Effective tax rate (%): 36.360606565572404
Interest coverage ratio: 1.288761885993004
COGS to revenue (%): 57.35824603441465
SG&A to revenue (%): 10.241477133613866
Free cash flow (dilution-adjusted): 21681084.872574233
Buyback yield (%): 0
Retained earnings: 302894552.2562544
Inventory turnover: 2.0003016934680518
Receivables turnover: 6.679815953595884
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.4038346667548876
FCF margin (%): 3.027196782481237
Revenue growth (%): -8.019262386908888
Rule of 40 score: -4.992065604427651
Financial ratios for RAYMONDLSL.NS — quarterly report dated 2025-06-30
Total revenue: 167380060.84717998
Gross profit: 72478352.44558859
Operating income: -1385443.482330915
Net income: -2319213.667212731
Capital expenditures: 0
Depreciation & amortization: 10395506.669787036
Owner earnings: 8076293.002574305
Buffett classification: The Gruesome
Stock price: 15.29780014041657
Shares outstanding: 60905789
Market cap (USD): 931724587.516382
Interest coverage ratio: -0.20609225413402957
COGS to revenue (%): 56.6983354655593
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.175013185638807
Rule of 40 score: -4.175013185638807
Financial ratios for RAYMONDLSL.NS — quarterly report dated 2025-12-31
Total revenue: 205939623.4822324
Gross profit: 92457391.11061603
Operating income: 16107831.123983514
Net income: 4774423.526790688
Capital expenditures: 0
Depreciation & amortization: 10286287.17834466
Owner earnings: 15060710.705135347
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.598418179792805
P/E ratio: 150.93438298071126
Shares outstanding: 60905789
Market cap (USD): 706410810.3922247
Effective tax rate (%): 30.34292215179587
Interest coverage ratio: 2.3964202850513754
COGS to revenue (%): 55.10461292137262
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 23.037130253081795
Rule of 40 score: 23.037130253081795
Financial ratios for RNGR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.75
Shares outstanding: 23761623
Market cap (USD): 231675824.25
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RNGR — annual report dated 2022-12-31
Total revenue: 608500000
Gross profit: 60200000
Operating income: 20300000
Net income: 15100000
Capital expenditures: 10500000
Operating cash flow: 44500000
Depreciation & amortization: 44400000
Net tangible assets: 259100000
Owner earnings: 49000000
Return on net tangible assets (%): 18.91161713624083
Capex to operating income (%): 51.724137931034484
Buffett classification: The Good
Stock price: 10.45
P/E ratio: 16.444302009933775
Shares outstanding: 23761623
Book value: 266200000
P/B ratio: 0.9327909855371901
Market cap (USD): 248308960.35
Debt to equity: 0.14312546957175057
Current ratio: 1.8805369127516778
Quick ratio: 1.8013422818791947
Effective tax rate (%): 5.625
Interest coverage ratio: 2.780821917808219
COGS to revenue (%): 90.10682004930156
SG&A to revenue (%): 6.557107641741988
Free cash flow (dilution-adjusted): 26900000
Buyback yield (%): 0
Retained earnings: 7100000
Inventory turnover: 92.9322033898305
Receivables turnover: 5.152413209144792
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.610224682513839
FCF margin (%): 4.420706655710764
Rule of 40 score: 4.420706655710764
Financial ratios for RNGR — annual report dated 2023-12-31
Total revenue: 636600000
Gross profit: 65000000
Operating income: 35500000
Net income: 23800000
Capital expenditures: 29700000
Operating cash flow: 90800000
Depreciation & amortization: 39900000
Net tangible assets: 265500000
Owner earnings: 34000000
Return on net tangible assets (%): 12.8060263653484
Capex to operating income (%): 83.66197183098592
Buffett classification: The Gruesome
Stock price: 9.8
P/E ratio: 9.784197705882354
Shares outstanding: 23761623
Book value: 271800000
P/B ratio: 0.8567472604856513
Market cap (USD): 232863905.4
Debt to equity: 0.08204562178072111
Current ratio: 1.96231884057971
Quick ratio: 1.8695652173913044
Effective tax rate (%): 23.225806451612904
Interest coverage ratio: 10.142857142857142
COGS to revenue (%): 89.78950675463399
SG&A to revenue (%): 4.633993088281495
Free cash flow (dilution-adjusted): 49500000
Buyback yield (%): 8.28810285855491
Retained earnings: 28400000
Inventory turnover: 89.3125
Receivables turnover: 6.17458777885548
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.488673139158575
FCF margin (%): 7.775683317624882
Revenue growth (%): 4.617912900575185
Rule of 40 score: 12.393596218200067
Financial ratios for RNGR — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 10900000
Buffett classification: The Gruesome
Stock price: 11.56
Shares outstanding: 23761623
Market cap (USD): 274684361.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RNGR — annual report dated 2024-12-31
Total revenue: 571100000
Gross profit: 54200000
Operating income: 26400000
Net income: 18400000
Capital expenditures: 31100000
Operating cash flow: 84500000
Depreciation & amortization: 44100000
Net tangible assets: 268200000
Owner earnings: 31400000
Return on net tangible assets (%): 11.707680835197614
Capex to operating income (%): 117.8030303030303
Buffett classification: The Gruesome
Stock price: 15.07
P/E ratio: 19.46128579402174
Shares outstanding: 23761623
Book value: 273800000
P/B ratio: 1.307843895580716
Market cap (USD): 358087658.61
Debt to equity: 0.08327246165084003
Current ratio: 2.207055214723926
Quick ratio: 2.1196319018404908
Effective tax rate (%): 29.230769230769234
Interest coverage ratio: 10.153846153846153
COGS to revenue (%): 90.50954298721766
SG&A to revenue (%): 4.867798984416039
Free cash flow (dilution-adjusted): 44600000
Buyback yield (%): 4.328549065378804
Retained earnings: 42200000
Inventory turnover: 90.6842105263158
Receivables turnover: 6.710928319623972
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.34386852085967
FCF margin (%): 7.8094904570127825
Revenue growth (%): -10.289035501099592
Rule of 40 score: -2.4795450440868096
Financial ratios for RNGR — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.07
Shares outstanding: 23761623
Market cap (USD): 358087658.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RNGR — quarterly report dated 2025-03-31
Total revenue: 135200000
Gross profit: 9200000
Operating income: 2100000
Net income: 600000
Capital expenditures: 6100000
Operating cash flow: 10600000
Depreciation & amortization: 10600000
Net tangible assets: 267200000
Owner earnings: 5100000
Return on net tangible assets (%): 1.908682634730539
Capex to operating income (%): 290.4761904761905
Buffett classification: The Gruesome
Stock price: 13.88
P/E ratio: 137.42138635
Shares outstanding: 23761623
Book value: 272600000
P/B ratio: 1.209872807190022
Market cap (USD): 329811327.24
Debt to equity: 0.08107116654438738
Current ratio: 2.303370786516854
Quick ratio: 2.2102728731942216
Effective tax rate (%): -20
Interest coverage ratio: 4.2
COGS to revenue (%): 93.19526627218934
SG&A to revenue (%): 5.2514792899408285
Free cash flow (dilution-adjusted): 1800000
Buyback yield (%): 0
Retained earnings: 41400000
Inventory turnover: 21.724137931034484
Receivables turnover: 1.5558112773302646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.668364099299809
FCF margin (%): 1.3313609467455623
Rule of 40 score: 1.3313609467455623
Financial ratios for RNGR — quarterly report dated 2025-06-30
Total revenue: 140600000
Gross profit: 14700000
Operating income: 7700000
Net income: 7300000
Capital expenditures: 5500000
Operating cash flow: 20700000
Depreciation & amortization: 10900000
Net tangible assets: 271700000
Owner earnings: 12700000
Return on net tangible assets (%): 4.674273095325727
Capex to operating income (%): 71.42857142857143
Buffett classification: The Good
Stock price: 11.74
P/E ratio: 35.311576458227854
Shares outstanding: 23761623
Book value: 276900000
P/B ratio: 1.007444759913326
Market cap (USD): 278961454.02
Debt to equity: 0.0780065005417118
Current ratio: 2.4730831973898857
Quick ratio: 2.3817292006525284
Effective tax rate (%): 27.722772277227726
Interest coverage ratio: 77
COGS to revenue (%): 89.5448079658606
SG&A to revenue (%): 4.978662873399715
Free cash flow (dilution-adjusted): 12800000
Buyback yield (%): 1.1829591337602536
Retained earnings: 47300000
Inventory turnover: 22.482142857142858
Receivables turnover: 1.5977272727272727
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.403245942571785
FCF margin (%): 9.103840682788052
Revenue growth (%): 3.9940828402366866
Rule of 40 score: 13.097923523024738
Financial ratios for RNGR — quarterly report dated 2025-09-30
Total revenue: 128900000
Gross profit: 8800000
Operating income: 2200000
Net income: 1200000
Capital expenditures: 5600000
Operating cash flow: 13600000
Depreciation & amortization: 11000000
Net tangible assets: 265000000
Owner earnings: 6600000
Return on net tangible assets (%): 2.490566037735849
Capex to operating income (%): 254.54545454545453
Buffett classification: The Gruesome
Stock price: 13.87
P/E ratio: 36.21689131978022
Shares outstanding: 23761623
Book value: 270000000
P/B ratio: 1.2206433741111111
Market cap (USD): 329573711.01
Debt to equity: 0.0737037037037037
Current ratio: 2.4656616415410384
Quick ratio: 2.3986599664991624
Effective tax rate (%): 52
Interest coverage ratio: 5.5
COGS to revenue (%): 93.17300232738557
SG&A to revenue (%): 5.120248254460822
Free cash flow (dilution-adjusted): 6300000
Buyback yield (%): 2.4880625262465776
Retained earnings: 47200000
Inventory turnover: 30.025
Receivables turnover: 1.435412026726058
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.7026509102523155
FCF margin (%): 4.887509697439875
Revenue growth (%): -8.321479374110954
Rule of 40 score: -3.4339696766710786
Financial ratios for RNGR — annual report dated 2025-12-31
Total revenue: 546900000
Gross profit: 44000000
Operating income: 14400000
Net income: 12300000
Capital expenditures: 23600000
Operating cash flow: 69000000
Depreciation & amortization: 46300000
Net tangible assets: 295200000
Owner earnings: 35000000
Return on net tangible assets (%): 11.856368563685638
Capex to operating income (%): 163.88888888888889
Buffett classification: The Gruesome
Stock price: 13.88
P/E ratio: 26.81392904390244
Shares outstanding: 23761623
Book value: 300100000
P/B ratio: 1.099004755881373
Market cap (USD): 329811327.24
Debt to equity: 0.10529823392202599
Current ratio: 1.7514450867052023
Quick ratio: 1.7066473988439306
Effective tax rate (%): 30.89887640449438
Interest coverage ratio: 12
COGS to revenue (%): 91.95465350155422
SG&A to revenue (%): 5.4123240080453465
Free cash flow (dilution-adjusted): 36400000
Buyback yield (%): 3.699084595454842
Retained earnings: 48900000
Inventory turnover: 162.2258064516129
Receivables turnover: 5.756842105263158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.113110539845758
FCF margin (%): 6.655695739623331
Revenue growth (%): -4.237436526002451
Rule of 40 score: 2.41825921362088
Financial ratios for RNGR — quarterly report dated 2025-12-31
Total revenue: 142200000
Gross profit: 11300000
Operating income: 2400000
Net income: 3200000
Capital expenditures: 6100000
Operating cash flow: 24100000
Depreciation & amortization: 13800000
Net tangible assets: 295200000
Owner earnings: 10900000
Return on net tangible assets (%): 3.692411924119241
Capex to operating income (%): 254.16666666666666
Buffett classification: The Gruesome
Stock price: 13.88
P/E ratio: 26.81392904390244
Shares outstanding: 23761623
Book value: 300100000
P/B ratio: 1.099004755881373
Market cap (USD): 329811327.24
Debt to equity: 0.10529823392202599
Current ratio: 1.7514450867052023
Quick ratio: 1.7066473988439306
Effective tax rate (%): 31.914893617021278
Interest coverage ratio: 12
COGS to revenue (%): 92.0534458509142
SG&A to revenue (%): 6.258790436005627
Free cash flow (dilution-adjusted): 15500000
Buyback yield (%): 0.21224255875560571
Retained earnings: 48900000
Inventory turnover: 42.225806451612904
Receivables turnover: 1.496842105263158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6855184233076265
FCF margin (%): 10.90014064697609
Revenue growth (%): 10.318076027928628
Rule of 40 score: 21.218216674904717
Financial ratios for RSMX.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -2186427.9411764704
Net income: -2317435.2941176468
Capital expenditures: 1121768.3823529412
Operating cash flow: -1923288.9705882352
Net tangible assets: 2821382.3529411764
Owner earnings: -3439203.676470588
Return on net tangible assets (%): -121.89782334483512
Buffett classification: The Gruesome
Stock price: 0.411764705882353
Shares outstanding: 138026099
Book value: 2821382.3529411764
P/B ratio: 20.14412403181586
Market cap (USD): 56834276.05882353
Debt to equity: 0
Current ratio: 4.14064557665857
Quick ratio: 4.14064557665857
Interest coverage ratio: -424.79171428571425
Free cash flow (dilution-adjusted): -3830228.676470588
Buyback yield (%): 0
Retained earnings: -5363897.794117646
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -77.49491801057053
Rule of 40 score: 0
Financial ratios for RSMX.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -2327890.909090909
Net income: -2413706.0606060605
Capital expenditures: 2668270.4545454546
Operating cash flow: -1510601.5151515151
Net tangible assets: 4700064.393939394
Owner earnings: -5081976.515151516
Return on net tangible assets (%): -108.12567848441795
Buffett classification: The Gruesome
Stock price: 0.25757575757575757
Shares outstanding: 138026099
Book value: 4700064.393939394
P/B ratio: 7.564189346213019
Market cap (USD): 35552177.015151516
Debt to equity: 0
Current ratio: 0.39932071719105156
Quick ratio: 0.39932071719105156
Free cash flow (dilution-adjusted): -4601836.363636363
Buyback yield (%): 0
Retained earnings: -7940146.212121212
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.52891522279273
Rule of 40 score: 0
Financial ratios for RSMX.V — quarterly report dated 2024-09-30
Gross profit: 0
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.2074074074074074
Shares outstanding: 138026099
Market cap (USD): 28627635.34814815
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RSMX.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: 0
Operating income: -1570450.3496503497
Net income: -1634664.3356643356
Capital expenditures: 312444.75524475524
Operating cash flow: -967742.6573426573
Depreciation & amortization: 0
Net tangible assets: 4385181.818181818
Owner earnings: -1947109.0909090908
Return on net tangible assets (%): -44.402015050687226
Buffett classification: The Gruesome
Stock price: 0.1188811188811189
Shares outstanding: 138026099
Book value: 4385181.818181818
P/B ratio: 3.7418510256250794
Market cap (USD): 16408697.083916085
Debt to equity: 0.00707914926460856
Current ratio: 0.18317574918150129
Quick ratio: 0.18317574918150129
Free cash flow (dilution-adjusted): -1504341.2587412589
Buyback yield (%): 0
Retained earnings: -8964030.069930071
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -35.812662160071824
Rule of 40 score: 0
Financial ratios for RSMX.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -435359.4405594406
Net income: -500649.65034965036
Capital expenditures: 220724.47552447554
Operating cash flow: -213930.76923076925
Net tangible assets: 4385181.818181818
Owner earnings: -721374.1258741259
Return on net tangible assets (%): -16.450267190362965
Buffett classification: The Gruesome
Stock price: 0.1188811188811189
Shares outstanding: 138026099
Book value: 4385181.818181818
P/B ratio: 3.7418510256250794
Market cap (USD): 16408697.083916085
Debt to equity: 0.00707914926460856
Current ratio: 0.18317574918150129
Quick ratio: 0.18317574918150129
Free cash flow (dilution-adjusted): -465871.32867132867
Buyback yield (%): 0
Retained earnings: -8964030.069930071
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.927967838285644
Rule of 40 score: 0
Financial ratios for RSMX.V — quarterly report dated 2025-03-31
Total revenue: 0
Gross profit: -565.7342657342657
Operating income: -144200.6993006993
Net income: -135269.23076923078
Capital expenditures: 102847.55244755246
Operating cash flow: -177251.04895104896
Depreciation & amortization: 565.7342657342657
Net tangible assets: 4534072.027972029
Owner earnings: -237551.048951049
Return on net tangible assets (%): -5.239242947300494
Buffett classification: The Gruesome
Stock price: 0.09790209790209792
Shares outstanding: 138026099
Book value: 4534072.027972028
P/B ratio: 2.9803330370529406
Market cap (USD): 13513044.65734266
Debt to equity: 0.006846683610635434
Current ratio: 0.20876528804908967
Quick ratio: 0.20876528804908967
Free cash flow (dilution-adjusted): -280098.60139860143
Buyback yield (%): 0
Retained earnings: -9099299.300699301
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.1803795442834315
Rule of 40 score: 0
Financial ratios for RSMX.V — quarterly report dated 2025-06-30
Total revenue: 0
Gross profit: -591.2408759124087
Operating income: -160877.37226277372
Net income: -187313.13868613137
Capital expenditures: 32093.430656934303
Operating cash flow: -113271.53284671532
Depreciation & amortization: 591.2408759124087
Net tangible assets: 4494535.03649635
Owner earnings: -218815.32846715325
Return on net tangible assets (%): -4.868475308131708
Buffett classification: The Gruesome
Stock price: 0.08029197080291971
Shares outstanding: 138026099
Book value: 4494535.036496351
P/B ratio: 2.465747273290369
Market cap (USD): 11082387.510948906
Debt to equity: 0.04781021168773821
Current ratio: 0.13698353210501055
Quick ratio: 0.13698353210501055
Free cash flow (dilution-adjusted): -145364.96350364963
Buyback yield (%): 0
Retained earnings: -9685121.897810219
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.5793996699641553
Rule of 40 score: 0
Financial ratios for RSMX.V — quarterly report dated 2025-09-30
Total revenue: 0
Gross profit: -582.0143884892087
Operating income: -554131.654676259
Net income: -656967.6258992807
Capital expenditures: 387475.53956834535
Operating cash flow: -750091.3669064749
Depreciation & amortization: 582.0143884892087
Net tangible assets: 6200841.726618705
Owner earnings: -1043861.1510791369
Return on net tangible assets (%): -16.834184730084225
Buffett classification: The Gruesome
Stock price: 0.1798561151079137
Shares outstanding: 138026099
Book value: 6200841.726618705
P/B ratio: 4.003462601387373
Market cap (USD): 24824837.94964029
Debt to equity: 0.004106195840202711
Current ratio: 2.8931968022788355
Quick ratio: 2.8931968022788355
Interest coverage ratio: -9.347949561270434
Free cash flow (dilution-adjusted): -1137566.9064748203
Buyback yield (%): 0
Retained earnings: -10202735.251798563
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.936394107553278
Rule of 40 score: 0
Financial ratios for SARO — annual report dated 2024-12-31
Total revenue: 5237161000
Gross profit: 754142000
Operating income: 404593000
Net income: 10974000
Capital expenditures: 101123000
Operating cash flow: 76330000
Depreciation & amortization: 187080000
Net tangible assets: -608754000
Owner earnings: 96931000
Return on net tangible assets (%): -15.922852252305528
Capex to operating income (%): 24.993759160440245
Buffett classification: The Great
Stock price: 24.76
P/E ratio: 750.1372358957536
Shares outstanding: 332471972
Book value: 2373404000
P/B ratio: 3.4684385914576703
Market cap (USD): 8232006026.72
Debt to equity: 1.0168150892136358
Current ratio: 1.9513530745698617
Quick ratio: 1.2862657277644118
Effective tax rate (%): 86.57729613366439
Interest coverage ratio: 1.4321521236641923
COGS to revenue (%): 85.60017536218574
SG&A to revenue (%): 4.851712597722316
Free cash flow (dilution-adjusted): -64231000
Buyback yield (%): 0
Retained earnings: -1563321000
Inventory turnover: 5.292708065235922
Receivables turnover: 3.477927758017516
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.190047199860244
FCF margin (%): -1.2264469242018718
Revenue growth (%): 14.767369289310068
Rule of 40 score: 13.540922365108196
Financial ratios for SARO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.76
Shares outstanding: 332471972
Market cap (USD): 8232006026.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SARO — quarterly report dated 2025-03-31
Total revenue: 1435588000
Gross profit: 217730000
Operating income: 128923000
Net income: 62943000
Capital expenditures: 25070000
Operating cash flow: -23986000
Depreciation & amortization: 48676000
Net tangible assets: -511102000
Owner earnings: 86549000
Return on net tangible assets (%): -16.93380186342452
Capex to operating income (%): 19.44571565973488
Buffett classification: The Great
Stock price: 26.64
P/E ratio: 35.178865537390976
Shares outstanding: 332471972
Book value: 2437968000
P/B ratio: 3.632965376936859
Market cap (USD): 8857053334.08
Debt to equity: 1.031927408399126
Current ratio: 2.0017707165599963
Quick ratio: 1.3743969571181445
Effective tax rate (%): 26.06422966687027
Interest coverage ratio: 2.9440524308647897
COGS to revenue (%): 84.83339231032859
SG&A to revenue (%): 4.491191065960429
Free cash flow (dilution-adjusted): -66369000
Buyback yield (%): 0
Retained earnings: -1500378000
Inventory turnover: 1.3904996563307082
Receivables turnover: 0.8317750457288898
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.527887586521567
FCF margin (%): -4.623123068735598
Rule of 40 score: -4.623123068735598
Financial ratios for SARO — quarterly report dated 2025-06-30
Total revenue: 1528943000
Gross profit: 236175000
Operating income: 135570000
Net income: 67713000
Capital expenditures: 18555000
Operating cash flow: 2883000
Depreciation & amortization: 48547000
Net tangible assets: -402192000
Owner earnings: 97705000
Return on net tangible assets (%): -24.293123682221427
Capex to operating income (%): 13.686656339898207
Buffett classification: The Great
Stock price: 31.65
P/E ratio: 80.53773201230712
Shares outstanding: 332471972
Book value: 2513283000
P/B ratio: 4.18684959624523
Market cap (USD): 10522737913.8
Debt to equity: 1.0133216195708958
Current ratio: 2.1544941088227993
Quick ratio: 1.4918897595522036
Effective tax rate (%): 26.186297487327632
Interest coverage ratio: 3.0927341165735145
COGS to revenue (%): 84.55305397258105
SG&A to revenue (%): 4.970885114749209
Free cash flow (dilution-adjusted): -37871000
Buyback yield (%): 0
Retained earnings: -1432665000
Inventory turnover: 1.5180513787624899
Receivables turnover: 0.8642270701384002
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.608377438006543
FCF margin (%): -2.4769399513258508
Revenue growth (%): 6.502910305742315
Rule of 40 score: 4.025970354416464
Financial ratios for SARO — quarterly report dated 2025-09-30
Total revenue: 1497962000
Gross profit: 223159000
Operating income: 137342000
Net income: 68120000
Capital expenditures: 18767000
Operating cash flow: 14799000
Depreciation & amortization: 48106000
Net tangible assets: -297462000
Owner earnings: 97459000
Return on net tangible assets (%): -32.763512650355345
Capex to operating income (%): 13.664428943804518
Buffett classification: The Great
Stock price: 27.29
P/E ratio: 45.64514889061054
Shares outstanding: 332471972
Book value: 2584948000
P/B ratio: 3.509997151153524
Market cap (USD): 9073160115.88
Debt to equity: 0.990669831656188
Current ratio: 2.179615552205761
Quick ratio: 1.4754243999811574
Effective tax rate (%): 26.57583857894283
Interest coverage ratio: 3.0817663689808374
COGS to revenue (%): 85.10249258659432
SG&A to revenue (%): 4.068461015699998
Free cash flow (dilution-adjusted): -8814000
Buyback yield (%): 0
Retained earnings: -1364545000
Inventory turnover: 1.3324570856384919
Receivables turnover: 0.8067647160202331
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.595946458580665
FCF margin (%): -0.5883994387040525
Revenue growth (%): -2.026301830741892
Rule of 40 score: -2.6147012694459444
Financial ratios for SARO — annual report dated 2025-12-31
Total revenue: 6062513000
Gross profit: 897453000
Operating income: 551069000
Net income: 277417000
Capital expenditures: 77284000
Operating cash flow: 316705000
Depreciation & amortization: 193664000
Net tangible assets: -182253000
Owner earnings: 393797000
Return on net tangible assets (%): -216.07161473336512
Capex to operating income (%): 14.02437807243739
Buffett classification: The Great
Stock price: 28.68
P/E ratio: 34.371708139587696
Shares outstanding: 332471972
Book value: 2667311000
P/B ratio: 3.5748722803452617
Market cap (USD): 9535296156.96
Debt to equity: 0.9182573760615091
Current ratio: 2.200393212376466
Quick ratio: 1.5716097017708992
Effective tax rate (%): 26.38568987294747
Interest coverage ratio: 3.1631184097992735
COGS to revenue (%): 85.19668328958635
SG&A to revenue (%): 4.085813919079431
Free cash flow (dilution-adjusted): 190657000
Buyback yield (%): 0
Retained earnings: -1285904000
Inventory turnover: 6.240323985641985
Receivables turnover: 3.4916778736087313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.514428912852594
FCF margin (%): 3.1448509883607674
Revenue growth (%): 15.759530783949549
Rule of 40 score: 18.904381772310316
Financial ratios for SARO — quarterly report dated 2025-12-31
Total revenue: 1600020000
Gross profit: 220389000
Operating income: 149234000
Net income: 78641000
Capital expenditures: 14892000
Operating cash flow: 323009000
Depreciation & amortization: 48335000
Net tangible assets: -182253000
Owner earnings: 112084000
Return on net tangible assets (%): -61.499124842938116
Capex to operating income (%): 9.978959218408674
Buffett classification: The Great
Stock price: 28.68
P/E ratio: 34.371708139587696
Shares outstanding: 332471972
Book value: 2667311000
P/B ratio: 3.5748722803452617
Market cap (USD): 9535296156.96
Debt to equity: 0.9182573760615091
Current ratio: 2.200393212376466
Quick ratio: 1.5716097017708992
Effective tax rate (%): 26.647016575100974
Interest coverage ratio: 3.551076740035693
COGS to revenue (%): 86.22585967675404
SG&A to revenue (%): 2.892588842639467
Free cash flow (dilution-adjusted): 303711000
Buyback yield (%): 0
Retained earnings: -1285904000
Inventory turnover: 1.6668430609974012
Receivables turnover: 0.9215245280845488
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.847393492249871
FCF margin (%): 18.98170022874714
Revenue growth (%): 6.8131234303673915
Rule of 40 score: 25.79482365911453
Financial ratios for SLQT — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.26
Shares outstanding: 176347774
Market cap (USD): 3396458127.2400002
Buyback yield (%): 0
Capitalized R&D asset: 18623000
Rule of 40 score: 0
Financial ratios for SLQT — annual report dated 2022-06-30
Total revenue: 764045000
Gross profit: 308345000
Operating income: -301413000
Net income: -297504000
Capital expenditures: 24798000
Operating cash flow: -338314000
Depreciation & amortization: 24724000
Net tangible assets: 314413000
Owner earnings: -297578000
Return on net tangible assets (%): -94.64557763196815
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 176347774
Book value: 391105000
P/B ratio: 1.118222675547487
Market cap (USD): 437342479.52
Debt to equity: 1.9050229478017413
Current ratio: 3.548254384960313
Quick ratio: 3.4975641556473707
Interest coverage ratio: -6.913935084298658
COGS to revenue (%): 59.64308384977325
R&D to revenue (%): 3.2365894678978333
SG&A to revenue (%): 76.56996642867894
Free cash flow (dilution-adjusted): -380015000
Buyback yield (%): 0
Retained earnings: -177100000
Inventory turnover: 79.1970802919708
Receivables turnover: 3.079845533076157
Capitalized R&D asset: 37206410
ROCI (R&D-adjusted, %): -23.986469013025282
FCF margin (%): -49.737253695790166
Rule of 40 score: -49.737253695790166
Financial ratios for SLQT — annual report dated 2023-06-30
Total revenue: 1002848000
Gross profit: 475361000
Operating income: 11583000
Net income: -58544000
Capital expenditures: 1447000
Operating cash flow: -19377000
Depreciation & amortization: 27881000
Net tangible assets: 292894000
Owner earnings: -32110000
Return on net tangible assets (%): -10.963010508921316
Capex to operating income (%): 12.492445825779159
Buffett classification: The Great
Stock price: 1.95
Shares outstanding: 176347774
Book value: 346970000
P/B ratio: 0.9910890258523791
Market cap (USD): 343878159.3
Debt to equity: 2.1091160619073697
Current ratio: 2.646305835039379
Quick ratio: 2.605746883583351
Interest coverage ratio: 0.14369898022479716
COGS to revenue (%): 52.598898337534706
R&D to revenue (%): 2.594111969111969
SG&A to revenue (%): 43.6519791633428
Free cash flow (dilution-adjusted): -39812000
Buyback yield (%): 0
Retained earnings: -235644000
Inventory turnover: 94.75246991198132
Receivables turnover: 3.7497494802650273
Capitalized R&D asset: 48729020
ROCI (R&D-adjusted, %): 1.280213315783265
Rosenberg metric: 6.7538517530025475
FCF margin (%): -3.9698937426210152
Revenue growth (%): 31.255096231242923
Rule of 40 score: 27.28520248862191
Financial ratios for SLQT — annual report dated 2024-06-30
Total revenue: 1321776000
Gross profit: 597974000
Operating income: 64550000
Net income: -34125000
Capital expenditures: 3129000
Operating cash flow: 15236000
Depreciation & amortization: 24998000
Net tangible assets: 263191000
Owner earnings: -12256000
Return on net tangible assets (%): -4.656694187871166
Capex to operating income (%): 4.847405112316034
Buffett classification: The Great
Stock price: 2.76
Shares outstanding: 176347774
Book value: 316801000
P/B ratio: 1.5363583329598074
Market cap (USD): 486719856.23999995
Debt to equity: 2.252922181432508
Current ratio: 1.906917468081816
Quick ratio: 1.8567533665164073
Interest coverage ratio: 0.6899979690222445
COGS to revenue (%): 54.75980801588166
R&D to revenue (%): 2.5362845141688153
SG&A to revenue (%): 37.820326590889835
Free cash flow (dilution-adjusted): -10246000
Buyback yield (%): 0
Retained earnings: -269769000
Inventory turnover: 82.64466773235898
Receivables turnover: 4.897171607893118
Capitalized R&D asset: 59114620
ROCI (R&D-adjusted, %): 6.489461713687339
Rosenberg metric: 4.713165481453008
FCF margin (%): -0.7751691663337812
Revenue growth (%): 31.802227256772714
Rule of 40 score: 31.02705809043893
Financial ratios for SLQT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.17
Shares outstanding: 176347774
Market cap (USD): 382674669.58
Buyback yield (%): 0
Capitalized R&D asset: 9074000
Rule of 40 score: 0
Financial ratios for SLQT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.72
Shares outstanding: 176347774
Market cap (USD): 656013719.2800001
Buyback yield (%): 0
Capitalized R&D asset: 16123580
Rule of 40 score: 0